-
Pegasus/Heartview LLC (PINKSHEETS: PGUZ) announced that they have now completed the required clinical studies, which are an integral part of the process required for the marketing of the Company's breakthrough HeartVue 6S Heart Screening System in North America....
-
The credit crunch may be taking its toll, but even if you're feeling the pinch, don't get out of heart healthy habits - a vegetable-rich diet doesn't have to be expensive. There are many ways for you and your family to get your five-a-day without going over-budget - here are ...
-
Cells obtained from menstrual blood, termed 'endometrial regenerative cells' (ERCs) are capable of restoring blood flow in an animal model of advanced peripheral artery disease. A study published in BioMed Central's open access Journal of Translational Medicine demonstrates that when circulation-blocked mice were treated with ERC injections, circulation and functionality ...
-
GE Healthcare along with Olympic medical leaders announced at the Beijing 2008 Olympic Games, initial findings that recognize risks for sudden cardiac death and musculoskeletal injuries before they happen. The findings come from two Olympic athlete research studies conducted since the Torino 2006 Olympic Winter Games aimed at demonstrating that ...
-
US research reveals that teenagers who don't sleep enough or have poor quality sleep may be at higher risk of elevated blood pressure that could lead to cardiovascular disease in adulthood. The study is the first to examine links between high blood pressure and sleep quality in healthy adolescents. The ...
-
Dyax Corp. (NASDAQ:DYAX) announced positive topline results from its second Phase 3, placebo-controlled trial, EDEMA4, for its lead product candidate DX-88 (ecallantide) for hereditary angioedema (HAE). The EDEMA4 trial, conducted under a Special Protocol Assessment granted by the U.S. Food and Drug Administration (FDA), achieved statistically significant improvements in the ...
